Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years

This manuscript discloses end-of-study safety data of a community-randomized controlled trial in Finland (NCT00534638), assessing the effectiveness of two vaccination strategies (gender-neutral versus females only) using the AS04-adjuvanted human papillomavirus (HPV)-16/18 (AS04-HPV-16/18) vaccine....

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dan Bi (Author), Dan Apter (Author), Tiina Eriksson (Author), Mari Hokkanen (Author), Julia Zima (Author), Silvia Damaso (Author), Maaria Soila (Author), Gary Dubin (Author), Matti Lehtinen (Author), Frank Struyf (Author)
Formato: Libro
Publicado: Taylor & Francis Group, 2020-06-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Dispoñible